Tab Application Banner
  • Users Online: 14
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
This article has been cited by
1Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis
Andreas Kerschbaumer,Alexandre Sepriano,Josef S Smolen,Désirée van der Heijde,Maxime Dougados,Ronald van Vollenhoven,Iain B McInnes,Johannes W J Bijlsma,Gerd R Burmester,Maarten de Wit,Louise Falzon,Robert Landewé
Annals of the Rheumatic Diseases.2020;79(6)744
[DOI]
2Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis
Alexandre Sepriano,Andreas Kerschbaumer,Josef S Smolen,Désirée van der Heijde,Maxime Dougados,Ronald van Vollenhoven,Iain B McInnes,Johannes W Bijlsma,Gerd R Burmester,Maarten de Wit,Louise Falzon,Robert Landewé
Annals of the Rheumatic Diseases.2020;79(6)760
[DOI]
3Comparative evaluation of efficacy, pharmacodynamics, and safety of Hetero’s adalimumab (Mabura®, Hetero Biopharma Ltd.) and reference adalimumab (Humira®, Abbvie Inc.) in patients with active rheumatoid arthritis on concomitant methotrexate therapy
Shubhadeep Sinha,Biswadip Ghosh,Syamasis Bandyopadhyay,Firdaus Fatima,Vamsi Krishna Bandi,Pankaj Thakur,Bala Reddy,Sreenivasa Chary,Leela Talluri,Ajay Gupta,Amit Ramchandra Kale,Anil Kumar Gupta,Ashok Kumar P,Diwakar Reddy,Younus Mohammed,Soma Shekar,Sudheer T,Vijay G. Goni,Vishnu Sharma,Vishwanath Yeligod
BMC Rheumatology.2020;4(1)760
[DOI]